Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Biggs

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Journal of Forensic Sciences|December 4, 2020
The use of lateral flow immunoassays for the detection of fentanyl in seized drug samples and postmortem urineDaniel J Angelini, Tracey D Biggs, Amber M Prugh, et al.
International Journal of Microbiology|July 28, 2011
Evaluation of handheld assays for the detection of ricin and staphylococcal enterotoxin B in disinfected watersMary Margaret Wade, Tracey D Biggs, Joseph M Insalaco, et al.
Australian Journal of Primary Health|January 7, 2024
A systematic search and narrative review of Aboriginal and Torres Strait Islander women and men pelvic health care: demonstrated need for improvementEmma M Wise, Marilyn A Morgan, Emily D Biggs, et al.
Genome Announcements|November 11, 2017
Whole-Genome Sequences of Variants of <i>Bacillus anthracis</i> Sterne and Their Toxin Gene Deletion MutantsA Staab, R D Plaut, C Pratt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trialSandra M Swain, Gong Tang, Charles E Geyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2012
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancerEdward H Romond, Jong-Hyeon Jeong, Priya Rastogi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2017
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2Patricia A Ganz, Edward H Romond, Reena S Cecchini, et al.
Physical Review Letters|October 9, 2002
Constraints on cosmological parameters from the analysis of the cosmic lens all sky survey radio-selected gravitational lens statisticsK-H Chae, A D Biggs, R D Blandford, et al.
JAMA Oncology|February 17, 2017
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical TrialsEthan Basch, Amylou C Dueck, Lauren J Rogak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609)Sylvia Adams, Megan Othus, Sandip Pravin Patel, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Journal of Forensic Sciences|December 4, 2020
The use of lateral flow immunoassays for the detection of fentanyl in seized drug samples and postmortem urineDaniel J Angelini, Tracey D Biggs, Amber M Prugh, et al.
International Journal of Microbiology|July 28, 2011
Evaluation of handheld assays for the detection of ricin and staphylococcal enterotoxin B in disinfected watersMary Margaret Wade, Tracey D Biggs, Joseph M Insalaco, et al.
Australian Journal of Primary Health|January 7, 2024
A systematic search and narrative review of Aboriginal and Torres Strait Islander women and men pelvic health care: demonstrated need for improvementEmma M Wise, Marilyn A Morgan, Emily D Biggs, et al.
Genome Announcements|November 11, 2017
Whole-Genome Sequences of Variants of <i>Bacillus anthracis</i> Sterne and Their Toxin Gene Deletion MutantsA Staab, R D Plaut, C Pratt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trialSandra M Swain, Gong Tang, Charles E Geyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2012
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancerEdward H Romond, Jong-Hyeon Jeong, Priya Rastogi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2017
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2Patricia A Ganz, Edward H Romond, Reena S Cecchini, et al.
Physical Review Letters|October 9, 2002
Constraints on cosmological parameters from the analysis of the cosmic lens all sky survey radio-selected gravitational lens statisticsK-H Chae, A D Biggs, R D Blandford, et al.
JAMA Oncology|February 17, 2017
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical TrialsEthan Basch, Amylou C Dueck, Lauren J Rogak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609)Sylvia Adams, Megan Othus, Sandip Pravin Patel, et al.
Pageof 11